Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Hypnosis to improve attention and reduce fatigue in stroke, TBI, and MS

Official title: Hypnosis and Attention in Patients With a Neurological Disease

Run by Luzerner Kantonsspital · NCT07256704 · Data updated 2026-11-12

This trial tests whether adding hypnosis to standard rehab can help adults with stroke, traumatic brain injury, or multiple sclerosis improve attention and feel less fatigued.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment48 (estimated)
SponsorLuzerner Kantonsspital
Academic / other
Locations1 site (Lucerne)
StatusRecruiting
StartedNovember 18, 2025
Main results expectedJuly 31, 2029
Study endsJuly 31, 2029
Registry record updatedAugust 14, 2026
Trial IDNCT07256704 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with a clinical diagnosis of stroke, TBI, or MS who are treated as inpatients or outpatients at the Clinic for Neurology and Neurorehabilitation, speak German, can consent, and do not have active psychiatric illness or EEG‑interfering implants are ideal candidates.

Probably not a fit

People with active psychiatric disorders, implanted neurostimulation devices or cochlear implants, scalp conditions that prevent EEG electrode placement, or who cannot follow German instructions may not benefit from or be eligible for this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with stroke, traumatic brain injury, or multiple sclerosis often have attention problems and reduced spontaneous visual exploration that limit daily function. This feasibility study integrates hypnosis sessions with participants' usual neurorehabilitation care and includes sham-hypnosis sessions while recording EEG to track brain activity during interventions. The team will measure feasibility and acceptability and look for preliminary changes in attention, free visual exploration, and fatigue using behavioral tests and EEG markers. Participants are German-speaking inpatients or outpatients at the Clinic for Neurology and Neurorehabilitation at Luzerner Kantonsspital who are 18 years or older and able to give informed consent.

Why it matters

Potential benefit: If successful, adding hypnosis could improve attention and reduce fatigue, helping people regain more independence in daily activities.

How similar studies have gone: Hypnosis has shown benefits in pain and fatigue in other medical settings, but its application to attention and visual exploration in stroke, TBI, and MS is relatively novel with limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ICD-10 Diagnosis of stroke, TBI or MS
* Admitted to the inpatient and/or outpatient in the Clinic for Neurology and Neurorehabilitation
* Age 18 years old or older
* Understanding the German language
* Written informed consent

Exclusion Criteria:

\- Psychiatric disease

Exclusion criteria for the EEG:

\- Scalp or skin conditions that interfere with EEG electrode placement (e.g. open wounds, infections, severe psoriasis) Implanted medical or neurostimulation devices that interfere with EEG electrode placement (e.g. deep brain stimulators, cochlear implants)

Where it's running

  • Luzerner Kantonsspital
    Lucerne, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.